Moderna Seeking Full FDA Approval for COVID-19 Vaccine


The US is closing in on the goal of having 70% of adults vaccinated by July 4.

This article was originally published in ContagionLive.

Moderna is moving forward with plans to apply for full approval for individuals 18 and up from the US Food and Drug Administration (FDA) for their COVID-19 vaccine.

The company has stated that it will be submitting trial data to the FDA on a rolling basis over the coming weeks. Moderna is seeking a priority review, which would give the FDA 6 months to take action on the approval. This comes after Pfizer announced last month that they have also begun the process of seeking full FDA approval for their COVID-19 vaccine.

Canada is set to receive 2.9 million doses of the Pfizer COVID-19 vaccine after the company announced they would increase their deliveries. For the month of May, Canada was receiving weekly deliveries of about 2 millions doses. Additional does of both Moderna and AstraZeneca vaccines are also expected, while expected doses of the Johnson and Johnson vaccine remain unclear. As of Sunday, Canada has reported 23 million doses administered, with around half of the population having received at least 1 shot.

After several issues have held up inoculation efforts in Venezuela, the campaign finally began again over this past weekend. To date, only around 1.1% of the population has received a dose of a COVID-19 vaccine. Around 1,000 people are expected to receive their first dose by end of day Monday.


661.47 million

45.96 per 100

United States

294.93 million

88.19 per 100


210.45 million

15.25 per 100


67.48 million

31.75 per 100

United Kingdom

64.92 million

95.63 per 100


49.94 million

59.61 per 100


36.22 million

53.61 per 100


34.95 million

57.81 per 100


28.5 million

19.53 per 100


27.05 million

9.89 per 100

Data Table per Our World in Data (May 30, 2021, 12 AM EST)

Despite a slowing in vaccination rates, the US is slowly getting closer to President Biden's goal of having 70% of the adult population receive at least one dose of a COVID-19 vaccine by July 4. As of Sunday, 62% of the adult population has gotten at least one shot and states all over the country are lifting their restrictions.



96.83 per 100



79.12 per 100

New York


100.78 per 100



87.08 per 100



98.20 per 100



91.85 per 100



84.59 per 100

New jersey


102.26 per 100



86.98 per 100



97.75 per 100

Data Table per CDC COVID-19 Tracker (May 24, 2021, 6 AM EST)

For more information on COVID-19 vaccination research, distribution, and assessment, check out some of these recent Contagion stories:

Pfizer-BioNTech COVID-19 Vaccine Achieves 100% Effectiveness in Adolescents

CDC Investigating Heart Inflammation in Teens Receiving COVID-19 Vaccine

FDA Issues EUA to Monoclonal Antibody for Treatment of COVID-19

Related Videos
Reviewing 2023 with FDA Commissioner Robert M. Califf, MD
A Year of RSV Highs and Lows, with Tina Tan, MD
Ryan A. Smith, MD: RSV Risk in Patients with IBD
Mikkael Sekeres, MD:
Julia Moore Vogel, PhD, MBA: How Do We Define Long Covid Patients?
Julia Moore Vogel, PhD, MBA: Long Covid Care Lacks Urgency
Balancing COVID-19 Risk and Wellness in Patients with Rheumatic Diseases
Exploring Patient Experiences, Challenges of Rheumatic Disease Management During the Pandemic
© 2024 MJH Life Sciences

All rights reserved.